Literature DB >> 8140420

Neutrophil activation by monomeric interleukin-8.

K Rajarathnam1, B D Sykes, C M Kay, B Dewald, T Geiser, M Baggiolini, I Clark-Lewis.   

Abstract

Interleukin-8 (IL-8), a pro-inflammatory protein, has been shown by nuclear magnetic resonance (NMR) and x-ray techniques to exist as a homodimer. An IL-8 analog was chemically synthesized, with the amide nitrogen of leucine-25 methylated to selectivity block formation of hydrogen bonds between monomers and thereby prevent dimerization. This analog was shown to be a monomer, as assessed by analytical ultracentrifugation and NMR. Nevertheless, it was equivalent to IL-8 in assays of neutrophil activation, which indicates that the monomer is a functional form of IL-8.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8140420     DOI: 10.1126/science.8140420

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  87 in total

1.  Anginex, a designed peptide that inhibits angiogenesis.

Authors:  A W Griffioen; D W van der Schaft; A F Barendsz-Janson; A Cox; H A Struijker Boudier; H F Hillen; K H Mayo
Journal:  Biochem J       Date:  2001-03-01       Impact factor: 3.857

2.  The monomer-dimer equilibrium and glycosaminoglycan interactions of chemokine CXCL8 regulate tissue-specific neutrophil recruitment.

Authors:  Pavani Gangavarapu; Lavanya Rajagopalan; Deepthi Kolli; Antonieta Guerrero-Plata; Roberto P Garofalo; Krishna Rajarathnam
Journal:  J Leukoc Biol       Date:  2011-12-02       Impact factor: 4.962

3.  Pancreatic Cancer Cell Migration and Metastasis Is Regulated by Chemokine-Biased Agonism and Bioenergetic Signaling.

Authors:  Ishan Roy; Donna M McAllister; Egal Gorse; Kate Dixon; Clinton T Piper; Noah P Zimmerman; Anthony E Getschman; Susan Tsai; Dannielle D Engle; Douglas B Evans; Brian F Volkman; Balaraman Kalyanaraman; Michael B Dwinell
Journal:  Cancer Res       Date:  2015-09-01       Impact factor: 12.701

4.  Sulfopeptide probes of the CXCR4/CXCL12 interface reveal oligomer-specific contacts and chemokine allostery.

Authors:  Joshua J Ziarek; Anthony E Getschman; Stephen J Butler; Deni Taleski; Bryan Stephens; Irina Kufareva; Tracy M Handel; Richard J Payne; Brian F Volkman
Journal:  ACS Chem Biol       Date:  2013-06-26       Impact factor: 5.100

5.  The solution structure of the anti-HIV chemokine vMIP-II.

Authors:  A C Liwang; Z X Wang; Y Sun; S C Peiper; P J Liwang
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

6.  Sometimes it takes two to tango: contributions of dimerization to functions of human α-defensin HNP1 peptide.

Authors:  Marzena Pazgier; Gang Wei; Bryan Ericksen; Grace Jung; Zhibin Wu; Erik de Leeuw; Weirong Yuan; Henryk Szmacinski; Wei-Yue Lu; Jacek Lubkowski; Robert I Lehrer; Wuyuan Lu
Journal:  J Biol Chem       Date:  2012-01-23       Impact factor: 5.157

Review 7.  The role of cervical cerclage in obstetric practice: can the patient who could benefit from this procedure be identified?

Authors:  Roberto Romero; Jimmy Espinoza; Offer Erez; Sonia Hassan
Journal:  Am J Obstet Gynecol       Date:  2006-01       Impact factor: 8.661

8.  The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin.

Authors:  Christopher T Veldkamp; Francis C Peterson; Adam J Pelzek; Brian F Volkman
Journal:  Protein Sci       Date:  2005-03-01       Impact factor: 6.725

9.  Proline substitution of dimer interface β-strand residues as a strategy for the design of functional monomeric proteins.

Authors:  Prem Raj B Joseph; Krishna Mohan Poluri; Pavani Gangavarapu; Lavanya Rajagopalan; Sandeep Raghuwanshi; Ricardo M Richardson; Roberto P Garofalo; Krishna Rajarathnam
Journal:  Biophys J       Date:  2013-09-17       Impact factor: 4.033

10.  Two glycosaminoglycan-binding domains of the mouse cytomegalovirus-encoded chemokine MCK-2 are critical for oligomerization of the full-length protein.

Authors:  Sergio M Pontejo; Philip M Murphy
Journal:  J Biol Chem       Date:  2017-04-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.